Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.5

-0.43

-0.36

-0.29

Details

Expected EPS

-0.415

Actual EPS

-0.44

Surprise EPS

-0.03

Surprise Percent

+6.02%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.44 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.